The docking protein Gab2 is overexpressed and estrogen regulated in human breast cancer

Roger J. Daly, Haihua Gu, Jayamala Parmar, Suzann Malaney, Ruth J. Lyons, Rania Kairouz, Darren R. Head, Susan M. Henshall, Benjamin G. Neel, Robert L. Sutherland

Research output: Contribution to journalArticleResearchpeer-review

85 Citations (Scopus)


Grb2-associated binder 2 (Gab2) is a recently identified member of the Gab/Daughter of sevenless family of docking proteins, which localize, amplify and integrate signaling pathways activated by various receptors including receptor tyrosine kinases (RTKs). To date, Gab2 signaling has been primarily investigated in hematopoietic cells. Here we report marked overexpression of Gab2 in a subset of breast cancer cell lines relative to normal breast epithelial strains and a trend for increased Gab2 expression in estrogen receptor (ER)-positive lines. Overexpression relative to normal ductal epithelium was also observed in some primary breast cancers. In MCF-7 breast cancer cells Gab2 was markedly tyrosine phosphorylated in response to heregulin and also following EGF, insulin or bFGF administration, indicating that a variety of RTKs implicated in breast cancer development or progression couple to this docking protein. In hormone-responsive breast cancer cells, GAB2 mRNA and protein expression were induced by estradiol in a manner sensitive to the pure anti-estrogen ICI 182780, indicating that this regulation is mediated via the ER. Gab2 therefore represents a novel link between steroid and growth factor signaling in breast cancer, and when over-expressed, may modulate the sensitivity of breast cancer cells to these important growth regulators.

Original languageEnglish
Pages (from-to)5175-5181
Number of pages7
Issue number33
Publication statusPublished - 1 Jan 2002
Externally publishedYes


  • Breast cancer
  • Growth factors
  • Signal transduction
  • Steroid hormones
  • Tyrosine kinase

Cite this